المؤلفون: Lajara, Rosemarie, Heller, Caroline, Pantalone, Kevin M., Lew, Elisheva, Li, Xuan, Dex, Terry, Kilpatrick, Catherine Rachel

المساهمون: Sanofi

المصدر: Diabetes, Obesity and Metabolism ; volume 25, issue 5, page 1249-1260 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.14974Test

المؤلفون: Polonsky, William H., Giorgino, Francesco, Rosenstock, Julio, Whitmire, Katherine, Lew, Elisheva, Coudert, Mathieu, Alvarez, Agustina, Nicholls, Charlie, McCrimmon, Rory J.

المصدر: Polonsky , W H , Giorgino , F , Rosenstock , J , Whitmire , K , Lew , E , Coudert , M , Alvarez , A , Nicholls , C & McCrimmon , R J 2022 , ' Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial ' , Diabetes, Obesity and Metabolism , vol. 24 , no. 12 , pp. 2364-2372 . https://doi.org/10.1111/dom.14822Test

مصطلحات موضوعية: basal insulin, GLP-1 analogue, glycaemic control, iGlarLixi, patient-reported outcomes, type 2 diabetes, /dk/atira/pure/subjectarea/asjc/1300/1310, name=Endocrinology, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/3e28bae5-142b-4d02-b565-e17271fba0d5Test

الإتاحة: https://doi.org/10.1111/dom.14822Test
https://discovery.dundee.ac.uk/en/publications/3e28bae5-142b-4d02-b565-e17271fba0d5Test
https://discovery.dundee.ac.uk/ws/files/79139950/Diabetes_Obesity_Metabolism_2022_Polonsky_Improved_patient_reported_outcomes_with_iGlarLixi_versus_premix_BIAsp_30_in.pdfTest
http://www.scopus.com/inward/record.url?scp=85136897014&partnerID=8YFLogxKTest

المؤلفون: McCrimmon, Rory J., Palmer, Karen, Alsaleh, Abdul Jabbar Omar, Lew, Elisheva, Puttanna, Amar

المصدر: McCrimmon , R J , Palmer , K , Alsaleh , A J O , Lew , E & Puttanna , A 2022 , ' Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK ' , Diabetes Therapy , vol. 13 , pp. 1203-1214 . https://doi.org/10.1007/s13300-022-01267-3Test

مصطلحات موضوعية: BIAsp 30, Cost-effectiveness, Cost-utility, iGlarLixi, Premix, SoliMix, Type 2 diabetes, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://discovery.dundee.ac.uk/en/publications/dbef844f-c2fb-4f84-a40a-0c92c3f8893cTest

الإتاحة: https://doi.org/10.1007/s13300-022-01267-3Test
https://discovery.dundee.ac.uk/en/publications/dbef844f-c2fb-4f84-a40a-0c92c3f8893cTest
https://discovery.dundee.ac.uk/ws/files/74382595/McCrimmon2022_Article_Cost_EffectivenessOfIGlarLixiV.pdfTest
https://discovery.dundee.ac.uk/ws/files/74382599/McCrimmon_SoliMix_UK_CEA_ms_Diabet_Ther_SUPP_REV_12Apr22.docxTest
http://www.scopus.com/inward/record.url?scp=85129875188&partnerID=8YFLogxKTest

المؤلفون: Shao, Hui, Alsaleh, Abdul Jabbar Omar, Dex, Terry, Lew, Elisheva, Fonseca, Vivian

المساهمون: Sanofi, France

المصدر: Diabetes Therapy ; volume 13, issue 9, page 1659-1670 ; ISSN 1869-6953 1869-6961

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1007/s13300-022-01300-5Test

المؤلفون: McCrimmon, Rory J., Falla, Edel, Sha, Jo Zhou, Alsaleh, Abdul Jabbar Omar, Lew, Elisheva, Hudson, Richard, Baxter, Mike, Palmer, Karen

المصدر: McCrimmon , R J , Falla , E , Sha , J Z , Alsaleh , A J O , Lew , E , Hudson , R , Baxter , M & Palmer , K 2021 , ' Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3217-3230 . https://doi.org/10.1007/s13300-021-01159-yTest

مصطلحات موضوعية: Cost-effectiveness, Cost-utility, Dulaglutide, GLP-1 receptor agonist, iDegLira, iGlarLixi, Liraglutide, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/9b18fb92-4700-472e-a7bd-cf9fda7c907eTest

الإتاحة: https://doi.org/10.1007/s13300-021-01159-yTest
https://discovery.dundee.ac.uk/en/publications/9b18fb92-4700-472e-a7bd-cf9fda7c907eTest
https://discovery.dundee.ac.uk/ws/files/68966155/McCrimmon2021_Article_Cost_EffectivenessOfIGlarLixiI.pdfTest
http://www.scopus.com/inward/record.url?scp=85118320249&partnerID=8YFLogxKTest

المؤلفون: McCrimmon, Rory J., Lamotte, Mark, Ramos, Mafalda, Alsaleh, Abdul Jabbar Omar, Souhami, Elisabeth, Lew, Elisheva

المصدر: McCrimmon , R J , Lamotte , M , Ramos , M , Alsaleh , A J O , Souhami , E & Lew , E 2021 , ' Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3231-3241 . https://doi.org/10.1007/s13300-021-01156-1Test

مصطلحات موضوعية: Cost-effectiveness, Cost-utility, GLP-1 receptor agonist, iGlarLixi, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/c57d2d6c-2e2f-4b69-8cfe-a4c817f69cd3Test

الإتاحة: https://doi.org/10.1007/s13300-021-01156-1Test
https://discovery.dundee.ac.uk/en/publications/c57d2d6c-2e2f-4b69-8cfe-a4c817f69cd3Test
https://discovery.dundee.ac.uk/ws/files/68965782/McCrimmon2021_Article_Cost_EffectivenessOfIGlarLixiV.pdfTest
http://www.scopus.com/inward/record.url?scp=85118336012&partnerID=8YFLogxKTest

المؤلفون: Kosoy, Irina, Lew, Elisheva, Ledanois, Olivier, Derrickson, William

المصدر: Journal of Asthma ; volume 59, issue 5, page 1021-1029 ; ISSN 0277-0903 1532-4303

الإتاحة: https://doi.org/10.1080/02770903.2021.1895208Test

المؤلفون: Su, Zhuo T., Bartelt-Hofer, Jose, Brown, Stephen, Lew, Elisheva, Sauriol, Luc, Annemans, Lieven, Grima, Daniel T.

المصدر: PHARMACOECONOMICS-OPEN ; ISSN: 2509-4262 ; ISSN: 2509-4254

مصطلحات موضوعية: Medicine and Health Sciences, TRANSPARENCY

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/8701540Test; http://hdl.handle.net/1854/LU-8701540Test; http://dx.doi.org/10.1007/s41669-019-0156-xTest; https://biblio.ugent.be/publication/8701540/file/8701543Test

الإتاحة: https://doi.org/10.1007/s41669-019-0156-xTest
https://biblio.ugent.be/publication/8701540Test
http://hdl.handle.net/1854/LU-8701540Test
https://biblio.ugent.be/publication/8701540/file/8701543Test

المؤلفون: Pantalone, Kevin M., Heller, Caroline, Lajara, Rosemarie, Lew, Elisheva, Li, Xuan, Dex, Terry, Kilpatrick, C. Rachel

المصدر: Diabetes Spectrum; Summer2023, Vol. 36 Issue 3, p253-263, 11p

مصطلحات موضوعية: INSULIN therapy, CONFIDENCE intervals, SCIENTIFIC observation, MULTIVARIATE analysis, RETROSPECTIVE studies, MEDICAL care costs, TYPE 2 diabetes, INSULIN, MEDICAL care use, DESCRIPTIVE statistics, DRUGS, HYPOGLYCEMIA, RESEARCH funding, PATIENT compliance, ODDS ratio, SUBCUTANEOUS injections, LONGITUDINAL method, PROPORTIONAL hazards models, ADULTS

مصطلحات جغرافية: UNITED States

المؤلفون: Raccah, Denis, Guerci, Bruno, Ajmera, Mayank, Davis, Keith, Meyers, Juliana, Lew, Elisheva, Shaunik, Alka, Blonde, Lawrence

المساهمون: Sanofi

المصدر: Endocrinology, Diabetes & Metabolism ; volume 2, issue 3 ; ISSN 2398-9238 2398-9238

الإتاحة: https://doi.org/10.1002/edm2.61Test